hydroxytyrosol

Botanicalexperimental

Hydroxytyrosol is an organic compound with the formula (HO)2C6H3CH2CH2OH. It is a phenylethanoid, i.e. a relative of phenethyl alcohol. Its derivatives are found in a variety of natural sources, notably olive oils and wines. Hydroxytyrosol is a colorless solid, although samples often turn beige during storage. It is a derivative, formally speaking, of catechol. — Wikipedia

Clinical trial activity

18 trials · 20 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
1

Earliest trial started Oct 1, 2010 (NCT01381354)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2016

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetAntioxidant

    antioxidant

Chemistry & pharmacology

Loading structure…

SMILES

OCCc1ccc(O)c(O)c1
Mol. weight
154.16 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 2-(3,4-dihydroxyphenyl)ethanol
  • 3,4-dihydroxyphenylethanol
  • beta-3,4-dihydroxyphenylethyl alcohol
  • dopet
  • hydroxytyrosol
  • hydroxytyrosol
  • hydroxytyrosol
  • hydroxytyrosol

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07074548N/AJul 10, 2025University of Indonesia
NCT07298759N/AJun 11, 2025University of Indonesia
NCT06992323N/AFeb 17, 2025Government of Spain, Olivenova Health Sl
NCT06833866Phase 1Dec 4, 2024Methodist Cancer Center, Houston, Texas, The University of Texas, Dallas
NCT06735222N/ANov 18, 2024Government of Spain, Olivenova Health Sl
NCT06295913N/ADec 1, 2023Government of Spain
NCT05472753N/ANov 16, 2022Government of Spain, University of Malaga
NCT06319417N/AApr 15, 2022Universidad Católica San Antonio de Murcia
NCT05679310N/AFeb 10, 2022University of Ioannina
NCT04876261N/AMay 10, 2021Antonio e Bandino Lo Franco Soc. Agr. Sempl., Daacro, Institut Kurz GmbH
NCT04520126N/ADec 1, 2020University of Athens
NCT04317079N/AOct 30, 2017University of Athens
NCT02842567Phase 3Sep 1, 2016Bambino Gesù Hospital and Research Institute
NCT02273622N/AOct 1, 2014Government of Spain
NCT02068092N/ADec 1, 2013Methodist Cancer Center, Houston, Texas, The Methodist Hospital System
NCT01983943N/AAug 1, 2013Mayo Clinic
NCT02042742Phase 4Apr 1, 2013Universidad Autonoma de Madrid
NCT01381354Phase 1Oct 1, 2010DJO Incorporated, Pinnaclife Inc., TZ Press, LLC, University of Iowa
Showing 18 of 18 trials
Page 1 / 1

Organizations

Research & Development (20)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Government of SpainGovernment5512014
Methodist Cancer Center, Houston, TexasAcademic/Hospital2022013
Olivenova Health SlAcademic/Hospital2012024
University of AthensAcademic/Hospital2212017
University of IndonesiaAcademic/Hospital2212025
Antonio e Bandino Lo Franco Soc. Agr. Sempl.Academic/Hospital1012021
Bambino Gesù Hospital and Research InstituteAcademic/Hospital1112016
DaacroFor profit1112021
DJO IncorporatedFor profit1012010
Institut Kurz GmbHAcademic/Hospital1012021
Mayo ClinicAcademic/Hospital1112013
Pinnaclife Inc.For profit1012010
The Methodist Hospital SystemAcademic/Hospital1112013
The University of Texas, DallasAcademic/Hospital1112024
TZ Press, LLCFor profit1012010
Universidad Autonoma de MadridAcademic/Hospital1112013
Universidad Católica San Antonio de MurciaAcademic/Hospital1112022
University of IoanninaAcademic/Hospital1112022
University of IowaAcademic/Hospital1112010
University of MalagaAcademic/Hospital1012022
20 organizations
Page 1 / 1